327 related articles for article (PubMed ID: 23423446)
1. A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.
Hein R; Flesch-Janys D; Dahmen N; Beckmann L; Lindström S; Schoof N; Czene K; Mittelstraß K; Illig T; Seibold P; Behrens S; Humphreys K; Li J; Liu J; Olson JE; Wang X; Hankinson SE; Truong T; Menegaux F; Dos Santos Silva I; Johnson N; ; Chen ST; Yu JC; Ziogas A; Kataja V; Kosma VM; Mannermaa A; Anton-Culver H; Shen CY; Brauch H; Peto J; Guénel P; Kraft P; Couch FJ; Easton DF; Hall P; Chang-Claude J
Breast Cancer Res Treat; 2013 Apr; 138(2):529-542. PubMed ID: 23423446
[TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
Rudolph A; Hein R; Lindström S; Beckmann L; Behrens S; Liu J; Aschard H; Bolla MK; Wang J; Truong T; Cordina-Duverger E; Menegaux F; Brüning T; Harth V; ; Severi G; Baglietto L; Southey M; Chanock SJ; Lissowska J; Figueroa JD; Eriksson M; Humpreys K; Darabi H; Olson JE; Stevens KN; Vachon CM; Knight JA; Glendon G; Mulligan AM; Ashworth A; Orr N; Schoemaker M; Webb PM; ; ; Guénel P; Brauch H; Giles G; García-Closas M; Czene K; Chenevix-Trench G; Couch FJ; Andrulis IL; Swerdlow A; Hunter DJ; Flesch-Janys D; Easton DF; Hall P; Nevanlinna H; Kraft P; Chang-Claude J;
Endocr Relat Cancer; 2013 Dec; 20(6):875-87. PubMed ID: 24080446
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.
Rudolph A; Fasching PA; Behrens S; Eilber U; Bolla MK; Wang Q; Thompson D; Czene K; Brand JS; Li J; Scott C; Pankratz VS; Brandt K; Hallberg E; Olson JE; Lee A; Beckmann MW; Ekici AB; Haeberle L; Maskarinec G; Le Marchand L; Schumacher F; Milne RL; Knight JA; Apicella C; Southey MC; Kapuscinski MK; Hopper JL; Andrulis IL; Giles GG; Haiman CA; Khaw KT; Luben R; Hall P; Pharoah PD; Couch FJ; Easton DF; Dos-Santos-Silva I; Vachon C; Chang-Claude J
Breast Cancer Res; 2015 Aug; 17(1):110. PubMed ID: 26275715
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.
Wang X; Kapoor PM; Auer PL; Dennis J; Dunning AM; Wang Q; Lush M; Michailidou K; Bolla MK; Aronson KJ; Murphy RA; Brooks-Wilson A; Lee DG; Cordina-Duverger E; Guénel P; Truong T; Mulot C; Teras LR; Patel AV; Dossus L; Kaaks R; Hoppe R; Lo WY; Brüning T; Hamann U; Czene K; Gabrielson M; Hall P; Eriksson M; Jung A; Becher H; Couch FJ; Larson NL; Olson JE; Ruddy KJ; Giles GG; MacInnis RJ; Southey MC; Le Marchand L; Wilkens LR; Haiman CA; Olsson H; Augustinsson A; Krüger U; Wagner P; Scott C; Winham SJ; Vachon CM; Perou CM; Olshan AF; Troester MA; Hunter DJ; Eliassen HA; Tamimi RM; Brantley K; Andrulis IL; Figueroa J; Chanock SJ; Ahearn TU; García-Closas M; Evans GD; Newman WG; van Veen EM; Howell A; Wolk A; Håkansson N; Anton-Culver H; Ziogas A; Jones ME; Orr N; Schoemaker MJ; Swerdlow AJ; Kitahara CM; Linet M; Prentice RL; Easton DF; Milne RL; Kraft P; Chang-Claude J; Lindström S
Sci Rep; 2022 Apr; 12(1):6199. PubMed ID: 35418701
[TBL] [Abstract][Full Text] [Related]
5. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
Li CI; Weiss NS; Stanford JL; Daling JR
Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
[TBL] [Abstract][Full Text] [Related]
10. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
11. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.
Prentice RL; Huang Y; Hinds DA; Peters U; Pettinger M; Cox DR; Beilharz E; Chlebowski RT; Rossouw JE; Caan B; Ballinger DG
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3079-85. PubMed ID: 19861516
[TBL] [Abstract][Full Text] [Related]
12. Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.
Schoeps A; Rudolph A; Seibold P; Dunning AM; Milne RL; Bojesen SE; Swerdlow A; Andrulis I; Brenner H; Behrens S; Orr N; Jones M; Ashworth A; Li J; Cramp H; Connley D; Czene K; Darabi H; Chanock SJ; Lissowska J; Figueroa JD; Knight J; Glendon G; Mulligan AM; Dumont M; Severi G; Baglietto L; Olson J; Vachon C; Purrington K; Moisse M; Neven P; Wildiers H; Spurdle A; Kosma VM; Kataja V; Hartikainen JM; Hamann U; Ko YD; Dieffenbach AK; Arndt V; Stegmaier C; Malats N; Arias Perez JI; Benítez J; Flyger H; Nordestgaard BG; Truong T; Cordina-Duverger E; Menegaux F; dos Santos Silva I; Fletcher O; Johnson N; Häberle L; Beckmann MW; Ekici AB; Braaf L; Atsma F; van den Broek AJ; Makalic E; Schmidt DF; Southey MC; Cox A; Simard J; Giles GG; Lambrechts D; Mannermaa A; Brauch H; Guénel P; Peto J; Fasching PA; Hopper J; Flesch-Janys D; Couch F; Chenevix-Trench G; Pharoah PD; Garcia-Closas M; Schmidt MK; Hall P; Easton DF; Chang-Claude J
Genet Epidemiol; 2014 Jan; 38(1):84-93. PubMed ID: 24248812
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
[TBL] [Abstract][Full Text] [Related]
14. Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.
Cordina-Duverger E; Truong T; Anger A; Sanchez M; Arveux P; Kerbrat P; Guénel P
PLoS One; 2013; 8(11):e78016. PubMed ID: 24223752
[TBL] [Abstract][Full Text] [Related]
15. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
Li CI; Malone KE; Porter PL; Lawton TJ; Voigt LF; Cushing-Haugen KL; Lin MG; Yuan X; Daling JR
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):43-50. PubMed ID: 18199710
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.
Cai Q; Long J; Lu W; Qu S; Wen W; Kang D; Lee JY; Chen K; Shen H; Shen CY; Sung H; Matsuo K; Haiman CA; Khoo US; Ren Z; Iwasaki M; Gu K; Xiang YB; Choi JY; Park SK; Zhang L; Hu Z; Wu PE; Noh DY; Tajima K; Henderson BE; Chan KY; Su F; Kasuga Y; Wang W; Cheng JR; Yoo KY; Lee JY; Zheng H; Liu Y; Shieh YL; Kim SW; Lee JW; Iwata H; Le Marchand L; Chan SY; Xie X; Tsugane S; Lee MH; Wang S; Li G; Levy S; Huang B; Shi J; Delahanty R; Zheng Y; Li C; Gao YT; Shu XO; Zheng W
Hum Mol Genet; 2011 Dec; 20(24):4991-9. PubMed ID: 21908515
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
Hoffman J; Fejerman L; Hu D; Huntsman S; Li M; John EM; Torres-Mejia G; Kushi L; Ding YC; Weitzel J; Neuhausen SL; Lott P; ; Echeverry M; Carvajal-Carmona L; Burchard E; Eng C; Long J; Zheng W; Olopade O; Huo D; Haiman C; Ziv E
Breast Cancer Res; 2019 Jan; 21(1):3. PubMed ID: 30642363
[TBL] [Abstract][Full Text] [Related]
18. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB
Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249
[TBL] [Abstract][Full Text] [Related]
19. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
20. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
